Data as of 1:02pm ET
| +0.03 / +1.17%|
The 1 analysts offering 12-month price forecasts for Idera Pharmaceuticals Inc have a median target of 7.00, with a high estimate of 7.00 and a low estimate of 7.00. The median estimate represents a +170.27% increase from the last price of 2.59.
The current consensus among 2 polled investment analysts is to Buy stock in Idera Pharmaceuticals Inc. This rating has held steady since August, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.